Pokroky v zobrazování tau-PET v Alzheimerově chorobě

Tento development of PET radioligands for the quantification of amyloid-β (Aβ) plaques over 20 years ago1 contributed substantially to Alzheimer's disease research. drug development, and clinical care. 10 years later, the development of radioligands for tau pathology,2 the second proteinopathy in Alzheimer's disease, has

Co funguje v praxi

Shrnutí

Tento development of PET radioligands for the quantification of amyloid-β (Aβ) plaques over 20 years ago1 contributed substantially to Alzheimer's disease research. drug development, and clinical care. 10 years later, the development of radioligands for tau pathology,2 the second proteinopathy in Alzheimer's disease, has

Klinický význam